SEATTLE, WA – CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing recent developments with Michael James Enterprises Inc. (OTCQB: MJTV). The company acquired the rights and intellectual property to develop and market therapeutics for sleep disorders using the cannabinoid dronabinol as the base ingredient in early August.
The Drug Enforcement Administration dashed hopes for federally-relaxed marijuana laws in August. Despite mounting scientific evidence, the drug czar decided to keep marijuana as a Schedule I Controlled Substance that has ‘no currently accepted medical value’. The irony is that the FDA had already approved a cannabinoid — dronabinol — back in 1985.
The decision is certainly a setback for the cannabis movement, but there are several companies that could benefit from the classification. Pharmaceutical companies that leverage cannabinoids benefit from mounting clinical evidence of safety and efficacy. Once approved, these companies can charge premium prices for their cannabinoid-based therapeutics without having to worry about competition from widely available medical marijuana.
In this article, we take a look at Michael James Enterprises Inc. (OTCQB: MJTV) and its plans to reformulate and enhance the delivery of dronabinol to target sleep disorders. Please click the link to read the article in full on CannabisFN.com: http://www.cannabisfn.com/mj-enterprises-mjtv-a-better-bet-on-cannabis-therapeutics/
Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone:https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:http://www.cannabisfn.com
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.